Deutsche Bank downgraded UnitedHealth (UNH) to Hold from Buy with a price target of $333, up from $275, following the Q3 report. The firm believes UnitedHealth’s “beat-and-raise story” has “no wiggle room” at current valuation levels. The shares at current levels price in the company’s earnings recovery in 2027 ad 2028 despite limited visibility into the turnaound at Optum Health, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth downgraded to Hold from Buy at Deutsche Bank
- UnitedHealth Group’s Q3 2025 Results and Outlook
- UnitedHealth Group’s Earnings Call Highlights Growth and Challenges
- UnitedHealth price target lowered to $417 from $423 at Piper Sandler
- Midday Fly By: OpenAI signs new Microsoft deal, PayPal reports Q3 beat